COO
The Cooper Companies, Inc. Common Stock
stock NASDAQ

Polypid Ltd just announced positive Phase 3 results for primary and secondary endpoint, ticker PYPD was rallying this morning currently up 23% but went above 40% as well. Given the market demand for this type of infection treatment, I think it could be a great company in the future but FDA approval is still approx. 1.5 years ahead. The medicine is basically an extended-release doxycycline but the release happens over weeks and months, in contrast to traditional antibiotics. It is engineered to treat surgical infections and reduce hospital costs when a patient gets infected during or following surgery due to infectious conditions in the hospital.
For more info on cash position and the medicine, check out this interview with their COO, uploaded 3 weeks ago on Youtube (https://youtu.be/bOA7_xNQO6o?si=J-XeQz2_pdZ4AKde)
Link for article: https://investors.polypid.com/news-releases/news-release-details/polypid-announces-positive-topline-results-phase-3-shield-ii

Cleaning lady here and I’m telling you, the CFO and COO don’t know what the CTO is cooking behind the curtains. I do, I read the papers left on the table. Upgrades are on the way.

Polypid Ltd just announced positive Phase 3 results for primary and secondary endpoint, ticker PYPD was rallying this morning currently up 23% but went above 40% as well. Given the market demand for this type of infection treatment, I think it could be a great company in the future but FDA approval is still approx. 1.5 years ahead. The medicine is basically an extended-release doxycycline but the release happens over weeks and months, in contrast to traditional antibiotics. It is engineered to treat surgical infections and reduce hospital costs when a patient gets infected during or following surgery due to infectious conditions in the hospital.
For more info on cash position and the medicine, check out this interview with their COO, uploaded 3 weeks ago on Youtube (https://youtu.be/bOA7_xNQO6o?si=J-XeQz2_pdZ4AKde)
Link for article: https://investors.polypid.com/news-releases/news-release-details/polypid-announces-positive-topline-results-phase-3-shield-ii

Cleaning lady here and I’m telling you, the CFO and COO don’t know what the CTO is cooking behind the curtains. I do, I read the papers left on the table. Upgrades are on the way.

Chairman of the Bitcoin Board and I’ve suspended the CEO, CFO and COO for violations of HR policies. DCA you fools…

COO here, concur that I said that it's possible.

I am CFO of Bitcoin, the COO says it is possible, but our financial analysis of external environment still registers many risks

[River's COO](https://theorg.com/org/river-financial/org-chart/julia-duzon) was Senior Director of Sales, Strategy, and Business Operations at [First Republic Bank](https://en.wikipedia.org/wiki/First_Republic_Bank#Collapse) for 6 years prior to it's collapse in 2023. I don't like dealing with companies who hire sketchy executives traditional finance won't touch.

Yes, Elon Musk is the CEO, Chief Technology Officer (CTO), and Chairman of SpaceX.
He founded the company in 2002 with the goal of revolutionizing space transportation and enabling the colonization of Mars, and he has remained at the helm ever since. While Gwynne Shotwell serves as President and COO, Musk maintains the top leadership positions and is heavily involved in the company's engineering and strategic direction.

Mit dem Absatz in China wird das alles wieder in Ordnung kommen.
Mein CEO, der Absatz ist nicht erfolgt.
Es bleiben im Raum CFO, COO und CMO.
Aber mein CEO, unsere Technologie ist stagniert...
DER ABSATZ IN CHINA WAR EIN BEFEHL!